Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Conference Sponsor
394
2023 - 03 - 21
点击次数:
上海优理惠生医药有限公司秉持“优异的科学,理想的药物”理念,为患者提供一系列包括采用合成致死策略在内的精准治疗组合。目前在研管线7个管线,其中有3个项目处于IND enabling阶段,预计2023年Q1有一个项目进入临床I期研究阶段。
395
2023 - 03 - 21
点击次数:
知易生物于2013年在广州开发区成立,目前已成为中国活体生物药领跑者,建成了国际水平的新功能菌株筛选与活体生物药研发平台,获批“广东省活体生物药工程技术研究中心”与“广州市创新领军团队”。公司研发的SK08是被中国药监局批准进入临床的第一个活体生物药原创品种,目前II期临床试验已完成。SK08联合抗PD-1/L1是中国药监局首次批准活体生物药用于肿瘤治疗的临床研究。2022年10月,公司开发的SK10(脆弱拟杆菌灭活型)获得了美国FDA的IND许可。知易生物已全面打通了LBP药物FDA\NMPA临床前开发的技术与注册路径。公司在广州科学城建成1万平米的研发中心与中试基地,包括两个GMP标准的中试车间,支持活体生物药面向中美注册的CMC研究及临床用药生产,是国内最先进的活体生物药中试与产业化平台。公司已完成了A轮5000万元、B轮3亿元的融资,得到行业广泛关注和认可。
396
2020 - 12 - 10
点击次数:
CrownBio is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research.Founded in 2006, CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today’s most advanced drug development challenges.Our portfolio translational platforms provide insight and understanding about a drug’s efficacy, pharmacological profile, and patient response profile. This reduce failure in the clinic and supports the selection of the right patients for the right therapy.CrownBio’s fast-paced R&D programs are yielding novel, yet well-validated models at the cutting-edge of disease research.In 2018, JSR Corporation acquired Crown Bioscience to be a strategic part of its global JSR Life Sciences division.